Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101443826-B1 |
titleOfInvention |
Medicinal composition |
abstract |
It is intended to provide a pharmaceutical composition containing a 2-nitroimidazole derivative having high solubility in an aqueous carrier and high stability. Characterized in that it contains 0.001 to 1 part by mass of creatinine per 1 part by mass of 1- (1-hydroxymethyl-2,3-dihydroxypropyl) oxymethyl-2-nitroimidazole and the compound. |
priorityDate |
2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |